Home
Conditions
Refractory Neuroblastoma

Clinical trial condition

Refractory Neuroblastoma

Explore clinical trials studying Refractory Neuroblastoma. Study availability and eligibility vary by location and protocol.

33 public trials 9 recruiting studies

Refine in advanced search Browse all conditions

Refractory Neuroblastoma trial results

Recruiting

PEEL-224, Vincristine and Temozolomide in Pediatric Solid Tumors

NCT06721689

Conditions: Disease Attributes, Myosarcoma, Neoplasms, +22 more
Locations: Cedars-Sinai Medical Center Los Angeles, California, United States

University of California, San Francisco San Francisco, California, United States

Boston Children's Hospital Boston, Massachusetts, United States

Dana-Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Recruiting

NKG2D.Zeta-NK Cell Conditioning With C7R.GD2.CAR-T Cells for Patients With Relapsed or Refractory Osteosarcoma or Neuroblastoma

NCT07211737

Conditions: Neoplasms, Neoplasms by Histologic Type, Neoplasms, Bone Tissue, +16 more
Locations: Texas Children's Hospital Houston, Texas, United States

View Trial Details

Recruiting

Feasibility Study of Prolonged Administration of Naxitamab, Irinotecan, and Temozolomide for Patients With Relapsed or Refractory Neuroblastoma

NCT07027748

Conditions: Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +10 more
Locations: Boston Children's Hospital Boston, Massachusetts, United States

Dana-Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Recruiting

Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma

NCT04901702

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +55 more
Locations: Lucille Packard Children's Hospital Stanford Palo Alto, California, United States

Children's Hospital Colorado Aurora, Colorado, United States

Children's National Medical Center Washington D.C., District of Columbia, United States

Children's Healthcare of Atlanta/Emory University School of Medicine Atlanta, Georgia, United States

View Trial Details

Recruiting

Dual-Target GD2/B7-H3 CAR-NK Cells for Pediatric Relapsed or Refractory Neuroblastoma

NCT07502287

Conditions: Disease Attributes, Ganglioneuroblastoma, High-risk Neuroblastoma, +15 more
Locations: Peking University Shenzhen Hospital Shenzhen, Guangdong, China

View Trial Details

Recruiting

GPC2 CAR T Cells for Relapsed or Refractory Neuroblastoma and Metastatic Retinoblastoma

NCT05650749

Conditions: Eye Diseases, Eye Diseases, Hereditary, Eye Neoplasms, +18 more
Locations: Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States

View Trial Details

Recruiting

Study of hALK.CAR T Cells for Patients With Relapsed/Refractory High-risk Neuroblastoma

NCT06803875

Conditions: High-risk Neuroblastoma, Neoplasms, Neoplasms by Histologic Type, +10 more
Locations: Boston Children's Hospital Boston, Massachusetts, United States

Dana-Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Recruiting

Allogeneic Expanded Gamma Delta T Cells With GD2 Chemoimmunotherapy in Relapsed /Refractory Neuroblastoma or Refractory/ Relapsed Osteosarcoma

NCT05400603

Conditions: Neoplasms, Neoplasms by Histologic Type, Neoplasms, Bone Tissue, +16 more
Locations: Children's Healthcare of Atlanta Atlanta, Georgia, United States

View Trial Details

Recruiting

NK Cells Infusions With Irinotecan, Temozolomide, and Dinutuximab

NCT04211675

Conditions: Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +9 more
Locations: Nationwide Children's Hospital Columbus, Ohio, United States

View Trial Details

Not Yet Recruiting

Testing the Addition of Iberdomide to Therapy in People With Neuroblastoma That Has Come Back, Not Responded to Treatment, or Gotten Worse

NCT07437963

Conditions: Ganglioneuroblastoma, Neoplasms, Neoplasms by Histologic Type, +12 more
Locations: Not specified

View Trial Details

Refractory Neuroblastoma

Refractory Neuroblastoma trial results

Related conditions